Biotech's surge pushes Bay Area companies — including a Covid drug hopeful — toward collective $1 billion in fresh funds
July 06, 2020 at 20:38 PM EDT
Three IPOs and four follow-on offerings are planned by companies working on treatments for a range of diseases, from cancer to Covid.
